Literature DB >> 18346151

Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure.

S Müller-Krebs1, L P Kihm, B Zeier, M L Gross, R Deppisch, A Wieslander, T Henle, I Penndorf, J Oh, J Reiser, P P Nawroth, M Zeier, V Schwenger.   

Abstract

BACKGROUND: In peritoneal dialysis (PD) residual renal function contributes to improved patient survival and quality of life. Glucose degradation products (GDP) generated by heat sterilization of PD fluids do not only impair the peritoneal membrane, but also appear in the systemic circulation with the potential for organ toxicity. Here we show that in a rat model of advanced renal failure, GDP affect the structure and function of the remnant kidney.
MATERIALS AND METHODS: Sprague-Dawley rats were randomly assigned to a two stage subtotal nephrectomy (SNX) or sham operation and were left untreated for 3 weeks. The SNX + GDP group continuously received chemically defined GDP intravenously for 4 weeks; the SNX and the sham-operated rats remained without GDP. The complete follow-up for all groups was 7 weeks postoperatively. We analysed renal damage using urinary albumin excretion as well as a semiquantitative score for glomerulosclerosis and tubulointerstitial damage, as well as for immunohistochemical analyses.
RESULTS: The SNX + GDP rats developed significantly more albuminuria and showed a significantly higher score of glomerulosclerosis index (GSI) and tubulointerstitial damage index (TII) as compared to SNX or control rats. In the SNX + GDP group the expression of carboxymethyllysine and methylglyoxal was significantly higher in the tubulointerstitium and the glomeruli compared to the SNX rats. Caspase 3 staining and TUNEL assay were more pronounced in the tubulointerstitium and the glomeruli of the SNX + GDP group. In SNX + GDP animals, the expression of the slit diaphragm protein nephrin, was significantly lower compared to SNX or control animals.
CONCLUSION: In summary, our data suggests that GDP can significantly advance chronic kidney disease and argues that PD solutions containing high GDP might deteriorate residual renal function in PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346151     DOI: 10.1111/j.1365-2362.2008.01945.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

1.  Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.

Authors:  Lars P Kihm; Sandra Müller-Krebs; Julia Klein; Gregory Ehrlich; Laura Mertes; Marie-Luise Gross; Antonysunil Adaikalakoteswari; Paul J Thornalley; Hans-Peter Hammes; Peter P Nawroth; Martin Zeier; Vedat Schwenger
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group.

Authors:  Claus Peter Schmitt; Sevcan A Bakkaloglu; Günter Klaus; Cornelis Schröder; Michel Fischbach
Journal:  Pediatr Nephrol       Date:  2011-03-31       Impact factor: 3.714

3.  Neuronal damage and shortening of lifespan in C. elegans by peritoneal dialysis fluid: Protection by glyoxalase-1.

Authors:  Andrea Schlotterer; Friederike Pfisterer; Georgi Kukudov; Britta Heckmann; Daniel Henriquez; Christian Morath; Bernhard K Krämer; Hans-Peter Hammes; Vedat Schwenger; Michael Morcos
Journal:  Biomed Rep       Date:  2018-04-03

4.  Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.

Authors:  J Haybrard; N Simon; C Danel; C Pinçon; C Barthélémy; F J Tessier; B Décaudin; E Boulanger; P Odou
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

Review 5.  [Peritoneal dialysis from the beginnings up to today: which developments of the last decades were important?].

Authors:  Andreas Vychytil
Journal:  Wien Med Wochenschr       Date:  2013-04-17

6.  Effect of the dialysis fluid buffer on peritoneal membrane function in children.

Authors:  Claus Peter Schmitt; Barbara Nau; Gita Gemulla; Klaus E Bonzel; Tuula Hölttä; Sara Testa; Michel Fischbach; Ulrike John; Markus J Kemper; Anja Sander; Klaus Arbeiter; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

7.  NFκB in the development of endothelial activation and damage in uremia: an in vitro approach.

Authors:  Carolina Caballo; Marta Palomo; Aleix Cases; Ana M Galán; Patricia Molina; Manel Vera; Xavier Bosch; Gines Escolar; Maribel Diaz-Ricart
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

Review 8.  Membrane nanotubes between peritoneal mesothelial cells: functional connectivity and crucial participation during inflammatory reactions.

Authors:  Julia Ranzinger; Amin Rustom; Vedat Schwenger
Journal:  Front Physiol       Date:  2014-10-24       Impact factor: 4.566

9.  Effect of benfotiamine in podocyte damage induced by peritoneal dialysis fluid.

Authors:  Sandra Müller-Krebs; Katharina Nissle; Julia Tsobaneli; Martin Zeier; Lars Philipp Kihm; Zoltan Kender; Thomas Fleming; Peter Paul Nawroth; Jochen Reiser; Vedat Schwenger
Journal:  Front Med (Lausanne)       Date:  2015-03-10

Review 10.  Is there such a thing as biocompatible peritoneal dialysis fluid?

Authors:  Claus Peter Schmitt; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2016-10-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.